197 related articles for article (PubMed ID: 28396635)
1. Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein Expression.
Leão AH; Meurer YS; da Silva AF; Medeiros AM; Campêlo CL; Abílio VC; Engelberth RC; Cavalcante JS; Izídio GS; Ribeiro AM; Silva RH
Front Aging Neurosci; 2017; 9():78. PubMed ID: 28396635
[TBL] [Abstract][Full Text] [Related]
2. Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and Spontaneously Hypertensive Rats (SHR): Implications for cognitive deficits in a progressive animal model for Parkinson's disease.
Leão AHFF; Meurer YSR; Freitas TA; Medeiros AM; Abílio VC; Izídio GS; Conceição IM; Ribeiro AM; Silva RH
Behav Brain Res; 2021 Jul; 410():113349. PubMed ID: 33971246
[TBL] [Abstract][Full Text] [Related]
3. Genetic effects in a progressive model of parkinsonism induced by reserpine.
Fadanni GP; Leão AHFF; Granzotto N; Pereira AG; de Gois AM; Anjos PAR; Linder ÁE; Santos JR; Silva RH; Izídio GS
Psychopharmacology (Berl); 2023 May; 240(5):1131-1142. PubMed ID: 36964320
[TBL] [Abstract][Full Text] [Related]
4. Female Rats Are Resistant to Cognitive, Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson's Disease.
Lima AC; Meurer YSR; Bioni VS; Cunha DMG; Gonçalves N; Lopes-Silva LB; Becegato M; Soares MBL; Marinho GF; Santos JR; Silva RH
Front Aging Neurosci; 2021; 13():757714. PubMed ID: 34759815
[TBL] [Abstract][Full Text] [Related]
5. Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine.
Lins LCRF; Souza MF; Bispo JMM; Gois AM; Melo TCS; Andrade RAS; Quintans-Junior LJ; Ribeiro AM; Silva RH; Santos JR; Marchioro M
Brain Res Bull; 2018 May; 139():9-15. PubMed ID: 29378222
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in the progressive model of parkinsonism induced by reserpine in rats.
Bispo JMM; Melo JEC; Gois AM; Leal PC; Lins LCRF; Souza MF; Medeiros KAAL; Ribeiro AM; Silva RH; Marchioro M; Santos JR
Behav Brain Res; 2019 May; 363():23-29. PubMed ID: 30690108
[TBL] [Abstract][Full Text] [Related]
7. Aging accentuates decrease in tyrosine hydroxylase immunoreactivity associated with the increase in the motor impairment in a model of reserpine-induced parkinsonism.
Melo JEC; Santos TFO; Santos RS; Franco HS; Monteiro MCN; Bispo JMM; Mendonça MS; Ribeiro AM; Silva RH; Gois AM; Marchioro M; Lins LCRF; Santos JR
J Chem Neuroanat; 2022 Nov; 125():102162. PubMed ID: 36115503
[TBL] [Abstract][Full Text] [Related]
8. Neuroinflammation in early, late and recovery stages in a progressive parkinsonism model in rats.
Cunha DMG; Becegato M; Meurer YSR; Lima AC; Gonçalves N; Bioni VS; Engi SA; Bianchi PC; Cruz FC; Santos JR; Silva RH
Front Neurosci; 2022; 16():923957. PubMed ID: 36090265
[TBL] [Abstract][Full Text] [Related]
9. Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine.
Santos JR; Cunha JA; Dierschnabel AL; Campêlo CL; Leão AH; Silva AF; Engelberth RC; Izídio GS; Cavalcante JS; Abílio VC; Ribeiro AM; Silva RH
Behav Brain Res; 2013 Sep; 253():68-77. PubMed ID: 23831411
[TBL] [Abstract][Full Text] [Related]
10. [Improvement effect of cinnamaldehyde on reserpine-induced Parkinson's disease rat model].
Jiao PP; Dong BB; Wu SH; Yan HM; Li HB; Li GL
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1318-1326. PubMed ID: 38621979
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and neurochemical effects induced by reserpine in mice.
de Freitas CM; Busanello A; Schaffer LF; Peroza LR; Krum BN; Leal CQ; Ceretta AP; da Rocha JB; Fachinetto R
Psychopharmacology (Berl); 2016 Feb; 233(3):457-67. PubMed ID: 26514557
[TBL] [Abstract][Full Text] [Related]
12. Testosterone propionate improves motor alterations and dopaminergic damage in the reserpine-induced progressive model of Parkinson's disease.
Bispo JMM; Melo JEC; Gois AM; Medeiros KAAL; Silva RS; Leal PC; Franco HS; Souza MF; Lins LCRF; Ribeiro AM; Silva RH; Santos JR
Brain Res Bull; 2022 Sep; 187():162-168. PubMed ID: 35781030
[TBL] [Abstract][Full Text] [Related]
13. Exposure to an enriched environment facilitates motor recovery and prevents short-term memory impairment and reduction of striatal BDNF in a progressive pharmacological model of parkinsonism in mice.
Campêlo CLC; Santos JR; Silva AF; Dierschnabel AL; Pontes A; Cavalcante JS; Ribeiro AM; Silva RH
Behav Brain Res; 2017 Jun; 328():138-148. PubMed ID: 28432010
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats.
Peres FF; Levin R; Suiama MA; Diana MC; Gouvêa DA; Almeida V; Santos CM; Lungato L; Zuardi AW; Hallak JE; Crippa JA; Vânia D; Silva RH; Abílio VC
Front Pharmacol; 2016; 7():343. PubMed ID: 27733830
[TBL] [Abstract][Full Text] [Related]
15. [Electroacupuncture improved locomotor function by regulating expression of tyrosine hydroxylase and α-synuclein proteins and transcription activating factor 6 and transcription factor X box binding protein 1 mRNAs in substantia nigra of rats with Parkinson's disease].
Ma J; Yuan L; Wang SJ; Lei J; Wang Y; Li YN; Yu BL
Zhen Ci Yan Jiu; 2019 Nov; 44(11):805-9. PubMed ID: 31777229
[TBL] [Abstract][Full Text] [Related]
16. Neonatal Reserpine Administration Produces Widespread Neuronal Losses and ⍺-Synuclein Inclusions in a Rat Model.
van Onselen R; Downing TG
Neurotox Res; 2021 Dec; 39(6):1762-1770. PubMed ID: 34727322
[TBL] [Abstract][Full Text] [Related]
17. Sleep deprivation induces late deleterious effects in a pharmacological model of Parkinsonism.
Lopes-Silva LB; Cunha DMG; Lima AC; Bioni VS; Gonçalves N; Kurita JPF; Wuo-Silva R; Silva RH
Exp Brain Res; 2024 May; 242(5):1175-1190. PubMed ID: 38499659
[TBL] [Abstract][Full Text] [Related]
18. Balance alterations and reduction of pedunculopontine cholinergic neurons in early stages of parkinsonism in middle-aged rats.
Dos Santos TFO; de R Santos E; Bispo JMM; de Souza MF; de Gois AM; Lins LCRF; Silva RH; Ribeiro AM; Marchioro M; Dos Santos JR
Exp Gerontol; 2021 Mar; 145():111198. PubMed ID: 33310153
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
20. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
